Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Private Equity topic

No spam. Unsubscribe anytime.

HPC releases policy brief on private equity in Massachusetts health care and outlines state policy options

Health Policy Commission · July 18, 2024
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The Health Policy Commission released a new policy brief documenting accelerated private-equity activity in Massachusetts health care and proposed state-level actions: amend notice-and-review rules to capture PE acquisitions, broaden registration thresholds to include self-pay/Medicare/Medicaid, and consider conditional approvals; commissioners discussed legislative timing and trade-offs.

The Health Policy Commission on July 18 released a policy brief synthesizing months of presentations and research on private-equity investment in Massachusetts health care and outlined several state policy options to increase transparency and oversight.

Staff described a decade-long rise in private-equity (PE) activity: in the commission’s dataset of 199 health care provider transactions from 2013–2023, staff reported that 51% (101 transactions) involved a private-equity firm and that PE activity is concentrated among behavioral health, home health, dental and certain specialty providers. "Private Equity is really leaving no stone," a presenter said, adding that PE ownership is difficult to track because of opaque corporate structures.

Commission staff summarized national research linking PE ownership to mixed quality and access outcomes: a systematic review found more studies reporting harmful impacts than improvements, and a Medicare-claims analysis discussed at the meeting associated PE hospital acquisitions with a higher rate of hospital-acquired conditions. "Private equity firms ... operate on a short timeline and expect high returns," the presenter said, describing common PE strategies such as leveraged buyouts and real-estate sale-and-leaseback arrangements.

To address oversight gaps, staff recommended state actions including: (1) amending material-change notice rules so the commission receives notice when a PE investor not previously operating in Massachusetts acquires a provider; (2) lowering or revising the provider registration revenue threshold (currently tied to a $25 million commercial-revenue threshold) to capture providers with self-pay, Medicare or Medicaid revenue; and (3) piloting a process for imposing conditions on transactions that raise concerns. Staff noted some proposals would require legislation; commissioners said draft bills with related provisions were under active legislative consideration.

Commissioners and presenters also discussed trade-offs—whether state review authority or alternative regulatory tools (including rate limits) are the most effective responses—and the need to track the cumulative market impact of serial acquisitions. Staff said longitudinal tracking of serial transactions is underway and recommended further research on exit strategies, bankruptcy patterns, and sector-specific vulnerabilities.

Staff said they intend to post the full policy brief publicly and to continue the commission’s research and outreach on private-equity impacts across the Commonwealth.